BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6202800)

  • 1. [Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate].
    Perrin P; Clairet F; Fleury-Goyon MC; Durand L
    J Urol (Paris); 1984; 90(1):19-22. PubMed ID: 6202800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)].
    Tellier JL; Chatal JF; Bourdin S; Auvigne J; Etienne P; Faye R
    J Urol (Paris); 1981; 87(3):169-73. PubMed ID: 7240777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of determining prostatic acid phosphatases by a radioimmunological method in cases of bony metastases].
    Mattei JP; Imbert I; Laugier-Catenacci E; Roux H
    Rev Rhum Mal Osteoartic; 1989 Feb; 56(2):147-9. PubMed ID: 2471253
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
    Canal P; Soula G
    Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
    Bruce AW; Mahan DE; Belville WD
    Urol Clin North Am; 1980 Oct; 7(3):645-52. PubMed ID: 7456177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of prostatic acid phosphatase in stage B and C prostatic cancer. Apropos of 84 cases].
    Guerin JL; Canal P; Douchez J; Soula G
    Bull Cancer; 1989; 76(10):1077-82. PubMed ID: 2635635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)].
    Pradalier N; Canal P; Pujol A; Fregevu Y; Soula G
    Ann Biol Clin (Paris); 1982; 40(1):45-50. PubMed ID: 7200750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy in prostatic carcinoma.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Cancer Res; 1981 Mar; 41(3):1180-3. PubMed ID: 7459859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase].
    Rassweiler J; Lutz K; Müller HA; Eisenberger F
    Urologe A; 1988 Jan; 27(1):32-5. PubMed ID: 2452506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
    Broghamer WL; Richardson ME; Faurest S; Parker JE
    Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E; Mari Ruiz M; Molina Andreu E
    Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid phosphatase.
    Henneberry MO; Engel G; Grayhack JT
    Urol Clin North Am; 1979 Oct; 6(3):629-41. PubMed ID: 388794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with adenocarcinoma or villous tumor of the rectum with collision phenomenon in a single lymph node: report of five cases.
    Mourra N; Parc Y; McNamara D; Tiret E; Flejou JF; Parc R
    Dis Colon Rectum; 2005 Feb; 48(2):384-9. PubMed ID: 15812588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostatic acid phosphatase measured by immunoenzyme assay].
    Fuse H; Zama S; Shimazaki J
    Hinyokika Kiyo; 1985 Nov; 31(11):1957-64. PubMed ID: 2418660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.